Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AP.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AP.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AP.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.40EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.4 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.2.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.4 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.4.2.4 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.4.2.4 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.4.2.4 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.2.4 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.2.4 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.161EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.161EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.161ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.161ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.161EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.161EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.161ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.161ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used